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Background: Planning radiosurgery to multiple intracranial metastases is complex and shows large variability in
dosimetric quality among planners and treatment planning systems (TPS). This project aimed to determine
whether autoplanning using the Muliple Brain Mets (AutoMBM) software can improve plan quality and reduce
inter-planner variability by crowdsourcing results from prior international planning study.
Methods: Twenty-four institutions autoplanned with AutoMBM on a five metastases case from a prior interna
tional planning competition from which population statistics (means and variances) of 23 dosimetric metrics and
resulting composite plan score (maximum score = 150) of other TPS (Eclipse, Monaco, RayStation, iPlan,
GammaPlan, MultiPlan) were crowdsourced. Plan results of AutoMBM and each of the other TPS were compared
using two sample t-tests for means and Levene’s tests for variances. Plan quality of AutoMBM was correlated with
the planner’ experience and compared between academic and non-academic centers.
Results: AutoMBM produced plans with comparable composite plan score to GammaPlan, MultiPlan, Eclipse and
iPlan (127.6 vs. 131.7 vs. 127.3 vs. 127.3 and 126.7; all p > 0.05) and superior to Monaco and RayStation (118.3
and 108.6; both p < 0.05). Inter-planner variability of overall plan quality was lowest for AutoMBM among all
TPS (all p < 0.05). AutoMBM’s plan quality did not differ between academic and non-academic centers and
uncorrelated with planning experience (all p > 0.05).

Abbreviations: AP, autoplanning; TPS, treatment planning system; SRS, stereotactic radiosurgery; DCA, dynamic conform arc; VMAT, volumetric modulated arc
radiotherapy; MLC, multi-leaf collimator; PCI, Paddict conformity index; GI, dose gradient index; R50%, spread of half isodose line; Vx Gy, volume receiving x Gy or
more; D x cm3, dose to x cm3 of the volume.
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Conclusions: By plan crowdsourcing prior international plan challenge, AutoMBM produces high and consistent
plan quality independent of the planning experience and the institution that is crucial to addressing the technical
bottleneck of SRS to intracranial metastases.

Introduction

generated in the experiment and the comparison arms, etc., prohibit
unbiased results and objective conclusions in the above single and multicenter planning studies.
To gain better insights into the potential of AP for multiple brain
metastases, a large scale multi-center study of the full range of planning
solutions that reflect a variety of academic and non-academic practices
should be performed. However, this requires extensive work to create
benchmark plans on multiple TPS with and without AP solutions.
Moghanaki et al. have recently adopted a crowdsourcing approach to
analyze the quality and variability of a large number of stereotactic body
radiotherapy plans for a single case of lung cancer using a web-based
platform [15]. Hardcastle et al. investigated the challenges of spinal
radiosurgery by crowdsourcing 149 plans of spinal radiosurgery from an
international plan challenge study that was organized by the TransTasmania Radiation Oncology Group (TROG) [16]. The same group
also crowdsourced 160 plans for a case of SRS to five brain metastases
from the other international planning study [17]. None of the 160
submissions to this planning competition was known to be auto-planned
by AutoMBM. The crowdsourcing approach offers the possibility to
efficiently benchmark plan solution belonging to a certain category of
treatment platform, delivery technique or TPS by crowdsourcing the
results that existed for the other categories from the cloud-database. The
feasibility of adapting the crowdsourcing approach has been demon
strated by Giles et al. to benchmark their in-house developed conformal
arc informed VMAT (CAVMAT) solution [18].
This Multi-Center Planning Radiosurgery for Intracranial Metastases
through Automation (MC-PRIMA) study adapted the crowdsourcing
approach to benchmark the performance of AutoMBM against the same
160 plans in the TROG planning study that were analyzed by Hardcastle
et al. [17]. But unlike their study that focused on the plan variability by
delivery technique (e.g., GammaKnife, CyberKnife, VMAT, intensity
modulated therapy), the primary objective of MC-PRIMA was to assess
the potential of AutoMBM to improve the quality and reduce the vari
ability of plans versus other existing TPS without dedicated AP solution
to SRS of multiple brain metastases. As secondary objective to under
stand how AutoMBM may address the technical demands of SRS plan
ning, the correlation of plan quality from AutoMBM with the planning
experience and the plan quality between academic and non-academic
centers were further evaluated.

Historically, stereotactic radiosurgery (SRS) was offered only to treat
limited number of lesions [1]. Recent evidences have been established to
show safety of SRS for patients with more than four lesions and even
beyond ten without compromised overall survival and increasing inci
dence of SRS-related adverse events [2–5].
Besides the prohibitively long treatment duration associated with
treating a large number of lesions, each of which may require additional
shots for GammaKnife and CyberKnife, or in the case of C-arm linac a
separate isocenter, the other major challenge is concerned with treat
ment planning. Planners typically rely on experience to determine and
iteratively refine a range of treatment platform-and delivery techniquespecific variables. A particular aspect of this exhaustive process is to
minimize the dose bridging between lesions, which leads to unwanted
high dose in the surrounding normal tissues. As the number of lesions
increases, the complexity of finding an optimal set of variables by, for
example, adjusting the size and shape of the collimation aperture and
the irradiation trajectory (e.g., beam incident angles) can rapidly
expand beyond the capacity of human planner. The planner’s experience
eventually becomes the determinator of the plan quality and main driver
of plan variability, which might not be adequately compensated with the
aid of general inverse-optimizers.
On the other hand, standardization of plan quality might not
necessarily be achieved through plan benchmarking, as shown by the UK
National Health Service commissioning of SRS service [6]. Despite
provision of detailed protocol, guidelines and feedbacks, for two plan
benchmark cases comprising three and seven lesions marked variations
of the SRS plans from 21 institutions were still noted not just between
treatment platforms but also within the same type of treatment platform.
The variation of plan quality was found to be particularly large among
institutions that deployed C-arm linacs for SRS indicative of strong
dependence of planner’s skill.
Automated planning (AP) through scripts, templates or plan library
solutions has demonstrated its potential to improve plans throughout
and plan quality in many disease sites [7–9]. Among a few commercially
available AP solutions, only two were developed with dedicated algo
rithms to address the unique problem of plan optimization for multiple
brain metastases. In a dual-center study, Haisong et al. found favourable
target dose conformity and intermediate dose volume 10 and 8 Gy
received by the normal brain in non-AP plans generated on the Eclipse
TPS (Varian, Palo Alto, CA, USA) for volumetric modulated arc radio
therapy (VMAT) delivery but worse low dose volume < 5 Gy compared
to those autoplanned by the Multiple Brain Mets SRSTM (AutoMBM;
Brainlab, Munich, Germany) software for dynamic conformal arc (DCA)
delivery [10]. In a more recent study by Hofmaier et al., the same
AutoMBM as used in Haisong et al. [10] was found to generate plans that
outperformed non-AP plans using the Monaco (Elekta, Stockholm,
Sweden) TPS for VMAT delivery [11]. Earlier, Gevaert et al. indicated
that AutoMBM was able to produce superior target dose conformity and
normal brain dose than manually optimized VMAT plans on Eclipse
[12]. Vergalasova et al. in another multi-center study found that the
DCA plans from AutoMBM produced generally worse target dose con
formity than the other AP solution of VMAT by HyperArcTM (Eclipse,
Varian) and non-AP solution of GammaKnife plans [13]. Nonetheless, all
these studies and others [6,14] merely reflect the experiences of
academically oriented practices and might not be generalizable to
clinical environments where quality control and improvement program
are less developed. The level of expertise of the participating in
stitutions, case selection and the limited number of plans that could be

Methods and materials
Recruitment of participants
This study involved as broad a spectrum of participants as possible to
emulate the constitution of participants in the TROG planning compe
tition. The final recruitment of participants included nine non-academic
and fourteen academic from seven regions (North / South America n =
2/2; Europe n = 15; Asia n = 2; Middle East n = 1; Africa n = 1; Aus
tralasian n = 1). The eligibility of institutions in MC-PRIMA was that
either the institution clinically use the autoplanning Multiple Brain Mets
SRSTM (AutoMBM) software to perform autoplanning (AP) or had un
dergone training from the vendor to use AutoMBM. Furthermore, these
institutions must have prior experiences with other SRS planning solu
tions. The vendor of AutoMBM was also invited to participate.
Plan study dataset, planning protocols and plan quality metrics
This study adapted the international planning study case of five brain
metastases that was originated from the Trans-Tasman Radiation
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Oncology Group (TROG) Local HER 0 trial [19]. This study case was
published through the publicly accessible web-based plan challenge
study platform ProKnow1 (Elekta, Stockholm, Sweden). The dataset
includes anonymized CT images from the skull apex to the second cer
vical vertebra and a set of tumor and normal organ contours defined
according to the Local HER 0 trial [19]. The resolution of the planning
CT is 1.0 × 0.468 × 0.468 mm3. These gross tumor volumes (GTV) of
sizes 0.52 (GTV1), 0.39 (GTV2), 0.07 (GTV3), 2.82 (GTV4) and 0.12
(GTV5) cm3 were defined in the frontal, parietal and temporal lobes and
the cerebellum adjacent to the brainstem. The sphericity of the GTV,
calculated using the OpenCAD extension to 3DSlicer [20] as a measure
of the roundness or spherical nature of the target, is 0.54, 0.59, 0.64,
0.59 and 0.66 for GTV1-5, respectively. The sphericity of a sphere is the
maximum value of 1. The smaller the value, the less the target ap
proaches to be spherical.
Other normal organs included in the study case were both eyes, lens,
optic nerves, hippocampuses, brainstem, optic chiasm and normal brain
(i.e., brain minus all GTVs). Per the Local HER 0 trial, GTVs were treated
without safety margin for microscopic disease (i.e., no clinical target
volume) and geometric uncertainty (i.e., no planning target volume),
and no planning risk volume (PRV) for normal organ was defined.

for individual targets, and the dose-volume constraints and their
strength on other critical organs when necessary. Final doses were
calculated pencil beam algorithm with adaptive dose calculation grid of
resolution from 0.63 to 1.25 mm3, except for one institution that applied
Monte Carlo dose-to-medium calculation at a resolution of 1.9 × 1.9 ×
2.0 mm3 and statistical uncertainty of 2 %.
Extraction and analysis of plan quality metric
For all cases, the dose matrices were exported in DICOM format of
uniform 1 mm3 resolution. The objective scoring algorithm underlying
the ProKnow platform was developed by Nelm et al. [21]. Each plan was
scored based on 23 metrics including target coverage per lesion, Paddick
conformity index (PCI) [22] and R50% [23] as a proxy to the steepness
of dose gradient per total as well as individual lesion volume, etc
(Supplementary Table S1).
Each metric has a maximum score and a baseline score for the ideal
value and the minimum requirement, respectively. Zero score was given
to metric that did not meet the minimum requirement. The sum of the
scores of these 23 metrics was total to 150 points. All scoring metrics
were obtained directly from the AutoMBM software and their values
were populated onto an Excel sheet (Microsoft Excel version 2102,
Microsoft Corporation, Redmond, USA) with formulae written specif
ically for this study to calculate their respective scores and the composite
score according to the exact scoring functions devised in the TROG
planning competition (Supplementary Table S1). It is important to note
that the dosimetry scoring matrix was based on the Local HER 0 trial
protocol [19] and did not necessarily reflect the clinical practice of in
dividual participant.
For comparison, this study crowdsourced the population statistics of
seven TPS (Table 1) that were employed in the TROG planning
competition. One of the TPS, Pinnacle (Philips Radiation Oncology
Systems, Fitchburg, WI, USA), was used in three plan submissions, its
population statistics were crowdsourced but were not included in the
statistical comparisons. Note that different techniques such as staticfield/arc modulated radiotherapy (IMRT / VMAT), dynamic arc radio
therapy (DCA) delivered with circular collimator or multileaf collimator
(MLC), and single or multiple isocenters may have been planned and
were combined to produce the population statistics per TPS. The pop
ulation statistics that are publicly accessible from the cloud-based Pro
Know system are the medians, means, and one standard deviations (S.

User process
Participants were provided with an instruction which included the
planning protocol and a web-link to download the plan dataset. Prior to
the start of planning, participants were advised to gain full under
standing of the planning protocol and the plan quality metrics. Partici
pants then performed AP using AutoMBM and uploaded the resulting
plan to the principal investigators for data analysis. Besides collection of
the SRS plans, experiences of the planners were documented.
Treatment planning with AutoMBM
The AutoMBM is an automated planning solution to treat multiple
brain metastases by mono-isocentric arc delivery with multileafcollimator (MLC) on C-arm linac. Different from the previous studies
that all used the early AutoMBM version 1.5, over half of our partici
pants planned with the later AutoMBM version 2.0 using different C-arm
linacs. Common to both versions is the template-driven automated
planning process. The planner define a set of templates called Clinical
Protocols and Setup Protocols each catering to specific treatment ob
jectives and irradiation geometry, respectively. Since version 2.0,
AutoMBM employs an inverse algorithm which actively optimizes target
heterogeneity, normal brain dose as well as OAR dose by optimizing
collimator angle, field shapes, arc weight (monitor unit) and BEV mar
gins. Besides the change of the optimization algorithm, AutoMBM v.2.0
adapts the highly automated planning approach to enable the users in
graphical interface to explicitly adjust the target dose homogeneity, the
dose constraints and their strength on the critical organs that may have
defined in the Clinical Protocol.
In order to perform crowd-knowledge-based planning benchmark of
AutoMBM against other non-AP treatment planning systems (TPS), the
same planning protocol, as defined in the original TROG planning
competition, was adhered to by this study (Supplementary Table S1)
except that all participants were demanded to achieve 20 Gy to cover
99% of every GTV as a hard constraint. Other plan quality metrics are
also given in Table S1. All institutions applied their own AP templates to
reflect their clinical practices. The general approach to achieve the
optimal plan quality metrics among institutions that planned by
AutoMBM v.1.5 was primarily by changing the AP template. Among
institutions planning by AutoMBM v.2.0, the dose distribution could
have been further optimized by adjusting the prescription isodose line
1

Table 1
Characteristics of the AutoMBM plan submissions in MC-PRIMA study.
Number of
institutions
Nominal photon energy
6MV
6MV – flattening filter free
MLC width (mm)
2.5 (inner 8 cm) and 5 (outer 14 cm); max field
size 22 × 30 cm2
5.0 (central 20 cm) and 10 mm (outer 20 cm);
max field size 40 × 40 cm2
5.0 ; max field size 40 × 40 cm2
Number of couch positions
≥3
>4
>5
>6
>7
Gantry arc length (◦ )
≥ 100
≥ 120
≥ 140
≥ 160

https://proknowsystems.com/
75

% of
total

15
9

62.5
37.5

18

75.0

2

16.7

4

8.3

24
22
3
1
0

100.0
91.7
12.5
4.2
0.0

Number of
treatment arcs
121
105
84
0

100.0
86.8
69.4
0.0
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D.) of the 23 plan quality metrics and their respective scores.
The PCI and dose gradient index (GI) [24] values per lesion that were
calculated automatically by the AutoMBM plans were also recorded for
quantitative analyses. Besides collection of the SRS plans, experiences of
the planners were documented.
All centers calibrated the machine output so that one monitor unit
gave one cGy at the depth of maximum dose for a reference 10 × 10 cm2
field.
Comparison of plan variability and quality between TPS
To facilitate statistical comparisons of the variability and averaged
performance of dose statistics between AutoMBM and each of the other
TPS, this study assumed that the sample followed a normal distribution
with sample number, mean and standard deviation known for each TPS.
For comparison of the standard deviation between AutoMBM and each
of the other TPS, the Levene’s tests were used. For comparison of mean,
we used the two sample t-tests with either equal or unequal variances for
PCI, R50%, GI, normal brain volume receiving 10 and 12 Gy (NBV10Gy
and NBV12Gy), maximum (Dmax) dose of the chiasm, eyes and lens, dose
to 0.3 cm3 (D0.3cc) of the brainstem, volume receiving 8 Gy (V8Gy) in the
optic nerves and mean dose (Dmean) to the hippocampuses, the com
posite plan score and the monitor units (MU) as complexity metrics [25],
according to the results of the preceding Levene’s tests. Normal distri
butions of different dose metrics were generated and statistical tests
were performed using Matlab v. R2018a (Mathwork Inc. MA, USA).
Dependence of AutoMBM plan quality on the planner’s experience and the
nature of the treating center
The potential of AutoMBM to lower or even eliminate the depen
dence of the plan quality in terms of composite plan score on the general
and SRS planning experiences and the nature of SRS treating center, i.e.,
academic vs. non-academic, were evaluated by Pearson’s correlation
and two sample t-test, respectively. Shapiro-Wilk tests for normality of
quantities in all correlation analyses were performed.
Results
Autoplanning with AutoMBM
Table 1 summarizes the characteristics of the AutoMBM submission
plans. The majority of institutions applied five table angles (19 of 24)
and a gantry arc length of 160◦ in the AP. Fig. 1 summarizes the distri
butions of the treatment table angle and the gantry arc length defined by
different planners in their AP templates, and the automatically opti
mized collimator angle.
All participants conformed to the requirement of 20 Gy covering 99%
of five targets. The prescription isodose line normalized to the maximum
dose ranges from 59 to 89% (mean ± one 1 SD = 80 ± 6%. Fig. 2 plots
the PCI (20 Gy) vs. GI for each GTV. Mean and SD of the PCI are 0.58 ±
0.05, 0.67 ± 0.05, 055 ± 0.09, 0.71 ± 0.04 and 0.67 ± 0.06, and for the
GI 4.41 ± 0.61, 4.47 ± 0.82, 6.55 ± 1.23, 3.23 ± 0.31 and 5.41 ± 0.92
for GTV 1 to 5, respectively. Fig. 3 shows the results of PCI, GI, R50% of
all GTVs, and normal brain volume receiving 12 and 10 Gy (NBV10Gy and
NBV12Gy) of the AutoMBM plans from individual participants.
Comparison of plan variability and quality between TPS
Table 2 gives the dosimetric results of the AP solution using
AutoMBM and non-AP solutions using other TPS that were crowd
sourced from the cloud-based ProKnow system. The statistical signifi
cance at p < 0.05 in the comparison of the mean and the standard
deviation is indicated by the bold value in Table 2. Supplementary
Table S2 gives the corresponding objective score for each evaluated
target and OAR, normalized to the respective maximum per TPS.

Fig. 1. Polar graphs showing the distributions of table, gantry angles covered
the arcs and collimator angles for twenty-four AutoMBM plans. Each axis (solid
grey) in these graphs represent the angle of the table, gantry and collimator and
the radial grid lines (dotted light grey) indicate the number of these table,
gantry and collimator angles, respectively.
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1.00

GTV 2

0.90

GTV 3

0.80

GTV 4
GTV 5

0.70

PCI

and-0.06 (p = 0.764), respectively. These statistical results are not
affected after adjusting for the potentially influential parameter of the
machine’s MLC width in the ANONVA tests. Furthermore, the difference
in the means of the composite score between academic and nonacademic centers is not significant (two sample t-test; p = 0.975), and
continues to be insignificant further adjusting for the technical factor of
MLC width (ANOVA; p = 0.481).

GTV 1

0.60

Discussions

0.50

The evaluation of automated stereotactic radiosurgery (SRS) plan
ning against other manual solutions by either inverse or forward opti
mization is often subject to bias even in multi-center studies. This study
overcame the classical limitation of planning benchmark by adapting a
prior web-based plan challenge study from which dose metric statistics
of 160 plans from a range of treatment planning systems (TPS) can be
crowdsourced. This allowed us to bypass the need to involve many in
stitutions to generate a large number of comparison plans yet enabling
adequate statistics power in the critical appraisal of autoplanning by the
Multiple Brain Mets SRSTM (AutoMBM) software. Another main
advantage of crowdsourcing plan results from a heterogeneity of aca
demic, non-academic and standalone institutions is that biases due to
the variables of individual experiences in SRS and equipment specific
characteristics (i.e., treatment machines) were effectively reduced.

0.40
0.30
0.20
0.10
0.00

0.00

2.00

4.00

6.00
GI

8.00

10.00

12.00

Fig. 2. Paddick Conformity index (PCI) vs. dose gradient index (GI) for indi
vidual gross tumor volumes (GTV) from twenty-four AutoMBM plans.

Characteristics of AutoMBM plans

Dependence of plan quality on the planner’s experience and the nature of
the treating center

The AutoMBM incorporates the user-defined template in its AP so
lution. By such AP approach the planner reserves some degree of
freedom to navigate the solution space for possible better plan dosim
etry. Definition of these templates and hence the beam geometry is
generally a non-trivial task, requiring certain level of expertise of the

The overall plan quality, evaluated by the composite score, shows no
dependence of the participants’ experience in SRS and general planning
(Fig. 4), with Pearson’s correlation coefficients r = -0.06 (p = 0.767)

Fig. 3. Paddick conformity index (PCI), spread of half prescription isodose (R50%), dose gradient index (GI) of all gross tumor volumes, normal brain volume
receiving 12 and 10 Gy (NBV12Gy and NBV10Gy, respectively) of the AutoMBM plans from individual participants.
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Table 2
Means ± one standard deviations (SD) of various dosimetric parameters calculated for AutoMBM and crowdsourced for different planning solutions from the cloudbased ProKnow platform.
Dosimetrics

Treatment planning system

Gross tumor volume
(GTV)

AutoMBM1 (n =
24)

Eclipse2 (n =
61)

Monaco3 (n =
47)

RayStation4 (n
= 6)

iPlan4 (n =
4)

MultiPlan6 (n =
16)

GammaPlan7 (n =
20)

Pinnacle8 (n
= 3)

GTV1V20Gy (%)
GTV2 V20Gy (%)
GTV3 V20Gy (%)
GTV4 V20Gy (%)
GTV5 V20Gy (%)
PCI of all GTVs(20 Gy)
R50% of all GTVs(10
Gy)

99.0 ± 0
99.0 ± 0
99.0 ± 0
99.0 ± 0
99.0 ± 0
0.71 ± 0.06
5.01 ± 0.73

98.8 ± 1.1
98.9 ± 1.0
98.9 ± 1.4
98.9 ± 1.4
98.8 ± 1.4
0.73 ± 0.09
5.48 ± 1.68

99.4 ± 0.5
99.4 ± 0.6
99.5 ± 0.6
99.1 ± 0.7
96.8 ± 0.8
0.64 ± 0.12
8.49 ± 6.60

99.4 ± 0.5
99.7 ± 0.3
99.6 ± 0.2
99.4 ± 0.7
99.0 ± 0.9
0.64 ± 0.02
9.70 ± 3.46

99.7 ± 0.3
99.7 ± 0.4
99.6 ± 0.3
81.1 ± 32.1
99.4 ± 0.4
0.54 ± 0.20
4.76 ± 0.90

99.2 ± 0.5
99.2 ± 0.7
98.2 ± 2.3
99.5 ± 0.4
98.5 ± 1.3
0.71 ± 0.06
4.65 ± 0.82

98.1 ± 1.5
98.1 ± 1.6
98.3 ± 1.5
98.7 ± 0.8
97.5 ± 2.9
0.69 ± 0.06
4.06 ± 0.44

99.7 ± 0.2
99.2 ± 0.3
99.3 ± 0.3
99.3 ± 0.2
99.4 ± 0.4
0.51 ± 0.10
11.85 ± 2.14

10.7 ± 1.9

10.9 ± 4.0

18.3 ± 15.5

19.0 ± 31.8

10.2 ± 2.1

9.4 ± 1.8

8.1 ± 1.2

10.2 ± 2.1

15.8 ± 2.5

16.6 ± 6.0

27.3 ± 23.0

31.8 ± 12.7

14.4 ± 2.8

13.5 ± 2.7

11.7 ± 1.7

37.8 ± 5.8

2.4 ± 0.6

1.8 ± 0.9

1.9 ± 1.2

2.3 ± 1.1

2.2 ± 1.1

1.8 ± 0.8

1.9 ± 0.2

2.0 ± 0.33

1.8 ± 0.3

1.3 ± 0.6

1.5 ± 1.7

0.6 ± 1.3

0.5 ± 0.5

1.3 ± 0.5

1.0 ± 0.1

1.4 ± 0.2

3.8 ±
4.0 ±
1.8 ±
1.6 ±
0.0 ±

1.2
1.2
0.5
0.4
0.0

4.0 ± 1.4
4.0 ± 1.2
1.5 ± 0.6
1.3 ± 0.5
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AutoMBM (Brainlab AG, Feldkirchen, Germany); 2Eclipse (Varian Inc. Palo Alto, CA, USA); 3Monaco (Elekta Oncology System, Crawley, UK); 4RayStation
(Raysearch Laboratories, Stockholm, Sweden); 5iPlan (Brainlab AG, Feldkirchen, Germany); 6MultiPlan (Accuray Inc., Sunnyvale, CA, USA); 7GammaPlan (Elekta AB,
Stockholm, Sweden);8Pinnacle (Philips Radiation Oncology Systems, Fitchburg, WI, USA). Note: Bold values indicate statistical significance (p < 0.05) between MBM1
and each of the other TPS2–8.

Fig. 4. Plot of radiosurgery and general planning experiences versus composite plan score of AutoMBM.

individual planner as in conventional planning. Fig. 1 depicts distinctive
preference among individual planners to use couch angle at 0◦ and 330◦
and to limit the couch angle to within 40◦ from 0◦ . The vast majority of
planners appeared to practice the similar planning philosophy that
avoided shoot-through the longitudinal body axis at either 90◦ or 270◦
couch angles. Fig. 1b also depicts the preference of most planners to use

half gantry arcs and to omit the first 10◦ –20◦ from either 0◦ or 180◦
respectively to avoid direct opposing beams. On the other hand, the
algorithm of AutoMBM overwhelmingly favored small collimator rota
tions, viz, 4◦ , although larger rotations over 30◦ were also observed. It is
worth noting that this study did not collect individual planner’s AP
templates and therefore was unable to analyze the minimum collimator
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angle defined therein. Nevertheless, most of the planners was believed to
have set the minimum collimator as 4◦ that was favourably chosen by
the AutoMBM. The auto-optimized collimator angle may depend on a
number of factors such as the couch angle, gantry arc span as well as the
machine characteristics (e.g., maximum field size and width of multileaf collimator (MLC), etc). For all plans that resulted in > 10◦ colli
mator rotation, the collimator aperture had a limited field size in one
dimension of 22 cm.

generally true for the dedicated SRS delivery platforms but not for the
linac-based platforms. The one S.D. of composite plan score is compa
rable between MultiPlan for CyberKnife (Accuray, CA, USA), Gamma
Plan for GammaKnife and AutoMBM. For CyberKnife planning on other
vendor-independent TPS which has recently become possible on RayS
tation, the proposed crowdsourcing approach is deemed to be useful to
efficiently evaluate the inter-institution / planner variability compared
with the vendor-dependent MultiPlan. For plans that were generated on
Monaco and Eclipse for linacs presumably belonging to the same ven
dors (Elekta and Varian, respectively), the excessive variability of
composite plan scores (p < 0.05) compared to AutoMBM could be partly
attributed to the absence of dedicated AP algorithm to manage the
overlapping of MLC apertures between targets and the sharing of same
pairs of MLC by two or more targets that increased the dose bridging
between targets in the normal brain. This problem also applied to the
other TPS independent of the linac vendor such as RayStation. As
demonstrated in previous studies [18,28,29], the dose bridging problem
cannot be easily resolved even with collimator angle optimization and
finer MLC width owing to the intrinsic limitation of the optimizer in
couple with MLC sequencer. In contrast, AutoMBM automated the
allocation of targets among arcs to treat as many targets by as many arcs
as possible by optimizing the collimator angle while avoiding two or
more metastases sharing the same pair of MLC. If two targets shared a
leaf pair, the targets were assigned to different arcs at the same couch
position. Else, both targets were assigned to the same arc. This fully
automated planning process was responsible for reducing the planner’s
intervention in the control of the intermediate-to-low dose spill and
consequently reduced the variability of R50%, and the normal brain
receiving 10 and 12 Gy (NBV10Gy and NBV12Gy, respectively).
The uniqueness of AutoMBM to achieve uniform target dose
coverage was clearly demonstrated in Table 2. For one reason, this study
demanded for every lesion that the planner must prescribe 20 Gy to
cover 99% of the GTV (GTV V20Gy). The algorithm of AutoMBM guar
anteed the precise prescription of GTV V20Gy = 99% by a stochastic
optimization of arc weights that followed the final dose distribution
resulting from the optimized arc configuration and dynamic arc MLC
sequencing. With other TPS, renormalization was inevitably needed
given deviations of the desired target coverage at the end of the final
dose calculation. This process involved non-trivial trade-off between
target coverage and PCI that varied according to the clinical preference
of individual planners and radiation oncologist. When separate plans
were created for different lesions, the optimal target coverage vs. PCI
that had been achieved by renormalization for one plan was likely to
change after plans for individual lesions were summed. This situation
necessitated repeated renormalization for every lesion by trial and error
until the planner achieved the global but also compromised optimality
of target coverage and PCI for all lesions. In case where all lesions were
co-optimized in one single plan, the renormalization after the final dose
calculation would affect the target coverage and PCI of individual le
sions all in once, making it nearly impossible to achieve uniform target
coverage.
As the overall effect, AutoMBM achieved significantly more uniform
composite plan score compared to other non-AP TPS for linac-based SRS,
as evidenced in Table 2. Moreover, the larger variability of plan quality
also suggested greater spread of plan complexity which was inferred by
the significantly larger number of monitor units [30].

Inter-planner variation in plan quality using AutoMBM and other nonAuto TPS
The heterogeneity of the template definition and machine charac
teristics did not appear to contribute to excessive variability in the plan
quality from AutoMBM. Considering two of the most concerning metrics
in SRS, the values of PCI and GI showed relatively small dispersion
among the institutions in each lesion (Fig. 2). Large GI (10.06 and 9.34)
and low PCI (0.30 and 0.36) all corresponded to the smallest lesion of
0.07 cm3. Interestingly, the machine characteristics, and more specif
ically concerning the width of the MLC, might not be the absolute factor
attributing to these outlying values as it seemed as there were other
AutoMBM plans created for the same type of machine and 5 mm MLC on
Elekta Agility (Elekta, Crawley, UK) and Varian Millenium 120 (Varian,
CA, USA) achieving GI of 6.89 and 6.84, and PCI of 0.53 and 0.56 for this
smallest lesion, respectively. Furthermore, the beam arc geometry of
these outlying plans did not differ substantially from other AutoMBM
plans either, regardless of the machine / MLC model. What may influ
ence the plan quality remains in the different settings of the Clinical
Protocol template and the level of planner-enabled interactive smart
tuning for controlling the degree of normal tissue sparing and MU spread
during the optimization.
An important aspect that influenced the variability of plan quality
among planners from different institutions is the treatment planning
system (TPS) in use. This study showed that AutoMBM did not differ
from most other TPS without using SRS-dedicated AP concerning the
variability of PCI, except for Monaco (Elekta, MO, USA) and iPlan
(BrainLab, Munich, Germany). There were, however, marked differ
ences in the inter-planner variability of R50% among TPS. AutoMBM
reduced this variability compared to some TPS, especially those that are
not dedicated to SRS such as Eclipse (Varian, CA, USA), Monaco and
RayStation (Raysearch, Stockholm, Sweden). The fact that the Gam
maPlan TPS dedicated to GammaKnife SRS (Elekta, Stockholm, Sweden)
achieved significantly smaller inter-planner variability in R50%
compared to AutoMBM was likely associated with the historical practice
of dose prescription at about the 50% isodose [26]. We also observed
such practice in most participants using GammaPlan whereas the dis
tribution of prescription isodose level was much wider for planners
using Eclipse, Monaco, and RayStation in the TROG planning competi
tion. The difficulty to achieve uniform PCI and GI using Monaco was
found even within the same institution. Hofmaier et al. obtained a wide
range of CI and GI values from 0.38-0.88 and 3.35–33.0 for the Monaco
plans, which were reduced to 0.58–0.89 and 3.50–15.73 by AutoMBM
[11]. Similar difficulty to obtain uniform GI within the same institution
was reported for Eclipse [11]. Gevaert et al. achieved GI at one standard
deviation (1 S.D.) of 3.1 vs. 1.6 planning VMAT on Eclipse without AP
and dynamic conformal arc (DCA) by AutoMBM, respectively [12]. On
the other hand, the majority of planners using iPlan were believed to
have performed forward dose optimization for DAC delivery using cir
cular collimator or MLC. Such approach is effective at producing good
target dose conformity when the target shape is fairly regular [27].
Given the poor sphericity of the targets in this TROG benchmark case,
the possibility of creating a complex dose distribution confirming to the
irregular targets’ surfaces became critically planner-dependent and
hence significant variability of the PCI.
One may anticipate lower variability of plan quality when plans were
generated for treatment platforms from the same vendor. This was

Overall plan quality between AutoMBM and other non-autoplan TPS
The ability of harmonizing the SRS plan quality is by far not enough
to consider AutoMBM as viable solution to SRS for multiple brain me
tastases. Equally important is that AutoMBM achieves plan quality
standard that is comparable to other non-AP TPS. Despite the statistical
significance, V20Gy of GTV1-5 was grossly comparable across different
TPS regardless of AP. One exception was observed with iPlan where the
mean V20Gy for GTV4 was merely 81% and was likely caused by an
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extreme outlier as indicated by the one S.D. of 31%.
The fact that MBM could not achieve comparable dose fall R50%,
NBV12Gy and NBV10Gy to dedicated radiosurgery TPS GammaPlan and
MultiPlan despite AP augmentation was not entirely surprising. It was
largely because AutoMBM was a AP solution to linac-based radiosurgery
using MLC that shows broader dosimetric penumbra compared with
conical collimators used in GammaKnife and CyberKnife. GammaPlan
and MultiPlan also used a large number of isocenters and non-isocenter
confocal beams which could significantly protect the normal brain and
other OARs than other TPS for non-coplanar radiosurgery on linacs
[31–34]. Nonetheless, the composite plan scores of GammaPlan, Mul
tiPlan and AutoMBM were statistically equal although AutoMBM
showed slightly worse dose statistics in other OARs in general. Because
the scoring functions (Supplementary Table S1) that were designed per
the Local HER-0 trial had higher weights on the target coverage,
AutoMBM scored more points from the ideal target coverage for all le
sions than GammaPlan and eventually equivalent composite plan score.
On the other hand, MultiPlan achieved almost full scores from target
coverage, and higher scores from better CI, NBV12Gy and other OARs and
eventually higher composite plan score despite statistical insignificance.
Rossi et al. have recently shown that the boundary of the CyberKnife
plan quality could be pushed even further by AP using the vendorindependent iCycle software in prostate radiotherapy [35]. As another
vendor-independent TPS has also become available for CyberKnife
planning, further crowdsourcing plan benchmark will provide more
insights into the role of TPS and the incorporation of AP in the overall
plan quality.
Results for linac-based SRS were different between TPS, with Eclipse
and iPlan showing very similar R50%, normal brain doses and doses in
other OARs to AutoMBM, while Monaco and RayStation almost reversed
the results in comparison to AutoMBM. Although Monaco and RaySta
tion scored almost the maximum possible points of 45.9 and 49.9 out of
50 for GTV V20Gy, the worse performance in PCI, R50%, NBV10Gy,
NBV12Gy and dose to 0.3 cc of brainstem (D0.3cc) rendered them to lose a
great deal of points to these high-weighted dosimetric metrics and ul
timately significantly lower composite plan scores. A possible reason for
these results could be that a large number of plans on Eclipse and iPlan
were created for Varian linacs assuming the finest MLC width of 2.5 mm
while Monaco for Elekta linacs assuming the finest MLC width of 4–5
mm [28,36,37]. Regardless of this hypothesis, it is still clear that plan
ners using AP–powered were able to overcome the influence of machine
/ MLC configuration and achieve comparable and even superior dose
statistics to other existing TPS. The ability of AP to reduce the plan
quality variability among treatment machines is not unique to
AutoMBM but also reported for other TPS in other treatment sites of
head and neck, pancreas and rectal cancers [38].

comparisons using the Levene’s tests for variance and the two sample ttests for mean represented the best effort and were deemed reasonable
for quantifying the relative performance of TPS. As this study focused on
TPS as the main factor that influenced the plan quality and variability,
the impact of delivery technique was ignored, which was partly due to
lack of the information about the delivery techniques that were planned
per TPS from the ProKnow system. Delivery technique is known to in
fluence the plan quality. For example, dosimetric comparisons showed
PCI and GI on the same TPS with VMAT better than IMRT [41] and
comparable between mono-and multi-isocentric DCA [12]. Contradic
tory results also existed comparing for the same delivery technique on
the same TPS, for example, cone-based vs. MLC-based DCA on linac
[8,42,43] and on CyberKnife [44,45]. Although institutions shall not be
limited with the choice of delivery technique, the above studies together
with the present MC-PRIMA suggest especially for linac-based SRS to
multiple brain metastases that the delivery technique(s) shall be care
fully chosen per TPS. We strongly recommend that organizers of inter
national plan competitions share detailed information of individual plan
submission on the web-platforms for their upcoming as well as past
studies such as the one for the TROG Local HER 0 trial study case. The
availability of this information is important to fully unlock the potential
of plan crowdsourcing when potentially interacting factors such as TPS,
machine characteristics and delivery technique could be taken into ac
count in the statistical analyses [46]. Upon the ultimate goal of knowl
edge sharing via could based plan crowdsourcing, SRS institutions can
be more informed of which TPS combined with what delivery technique
to avoid suboptimal and large variability of plan quality.
The plan complexity has an implication on the plan deliverability
[25]. In the original TROG plan competition and this study involving a
spectrum of delivery techniques planned by different TPS, the number of
MU per Gy may be the most simplest and applicable complexity metrics
for evaluation and comparison of the relative plan deliverability be
tween TPS [47]. Other complexity metrics, such as modulation
complexity score [48] and variations of the nominal dose rate or gantry
speed [49], etc, suffer from limited application to certain delivery
technique that could be planned by certain TPS and therefore unsuitable
for this study. In Table 2, the MU resulting from AutoMBM was found to
be significantly lower than from other TPS, which may result in superior
deliverability [30]. Although highly recommended [40], a dry-run test
for the deliverability and the dosimetric accuracy of the AutoMBM
submission plan was not requested in MC-PRIMA. It is common that the
post-planning dosimetric validation was left out in non-sponsored multicenter planning studies [10,13,46,50], like MC-PRIMA, predominately
because financial resource was generally beyond reach to arrange
rigorous dosimetry audit like in clinical trials. Nonetheless, all in
stitutions that participated in MC-PRIMA had rigorous commissioning
program and routine plan quality assurance in place to demonstrate
acceptable deliverability and accuracy of their clinical AutoMBM plans.

Limitations
The dosimetric scoring matrix and the eventual composite plan score
were uniquely devised based on Local HER-0 trial protocol. There was
other cloud-based international plan challenge study that used different
scoring matrix [18]. Although the interpretation of overall plan quality
may change with the scoring algorithm and the definition of the plan
quality [39], the results that AutoMBM could reduce the inter-planner
variability and improve the averaged performance of a range of dose
metrics remain valid. The retrospective nature of this study precluded
the case selection bias in favor of AutoMBM. Nevertheless, there was a
rare possibility of bias stemming from the prior knowledge of scores by
the other TPS which might steer the participants to work strategically on
certain scoring metrics to higher scores. Yet, this study achieved RAT
ING scores of 94% and 92% by two authors (XX and XX) [40].
It was acknowledged that the statistical comparisons may be subject
to debate because of the assumption of normality in the scoring metrics.
The ProKnow system provided only the population statistics of dosi
metric results per either TPS or delivery technique. Statistical

Dependence of plan quality on the planner’s experience and the nature of
treating center
This study collected information about the planning experience of
each individual planner. When the composite plan score was plotted
versus the general planning and radiosurgery planning experience of the
planner, no significant correlations were found. Plan scores resulting
from those planners from academic were also compared with the others
from non-academic centers, again without observed significant differ
ence. Other studies [51,52] have showed that AutoMBM could outper
form human planners but this study, to our best knowledge, is the first to
demonstrate that AutoMBM could also eliminate the dependence of plan
quality on the planning experiences and the nature of the treating cen
ter. When radiosurgery is increasingly applied to treat multiple brain
metastases, AutoMBM proves to offer a viable option to alleviate the
problem of global shortage of planners / dosimetrists that typically take
years to develop their expert skills. Further crowdsourcing plan
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benchmark from other cloud-based international plan challenge studies
is warranted to validate the results of this MC-PRIMA study and to
investigate that other AP in general are able to improve plan quality and
variability in SRS planning for multiple brain metastases.
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Conclusions
Plan crowdsourcing offers an efficient means to benchmark new TPS
or delivery technique. This plan crowdsourcing study shows promises of
AutoMBM to achieve clinically acceptable plans with minimal interplanner variability for SRS to multiple intracranial metastases inde
pendent of the planning experience and the institution.
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